Status:
COMPLETED
Agonist Replacement Therapy for Cocaine Dependence
Lead Sponsor:
University of Kentucky
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Cocaine Dependence
Eligibility:
All Genders
18-50 years
Phase:
PHASE1
Brief Summary
Cocaine dependence is a significant public health concern. The proposed research will provide important clinical information regarding the efficacy of agonists replacement therapies for managing cocai...
Detailed Description
Cocaine abuse and dependence continue to be significant public health concerns. The number of Americans that used cocaine in the past month, the percentage of 12th-, 10th- and 8th-graders that used co...
Eligibility Criteria
Inclusion
- Must meet diagnostic criteria for cocaine dependence Current cocaine use at study entry, as determined by urine screen Body Mass Index less or equal to 30 ECG results within normal limits If female, willing to use contraception throughout study
Exclusion
- Meets diagnostic criteria for dependence on drug other than cocaine and nicotine Currently seeking treatment for substance abuse Current or past history of serious illness including impaired heart function, seizures and central nervous system tumors Family history o heart disease or seizures Current of past psychiatric disorder other than substance abuse Pregnant
Key Trial Info
Start Date :
June 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2012
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT00697138
Start Date
June 1 2006
End Date
January 1 2012
Last Update
March 1 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Kentucky Medical Center
Lexington, Kentucky, United States, 40536 0086